“2 “Strong Buy” Penny Stocks That Could See Outsized Gains”
January 21, 2021
“AzurRx BioPharma (AZRX)…
Overall, the analyst consensus on AZRX shares is a Strong Buy; the stock has 4 recent reviews, including 3 Buys and a single Hold. In addition, the $4 average price target brings the upside potential to 304%…
ProQR (PRQR)…
All in all, PRQR gets a unanimous Strong Buy rating from the analyst consensus, based on 3 positive stock reviews. Shares are currently trading for $4.13, and their $20.67 average price target is slightly more bullish than Wolleben’s, suggesting an upside of 400% for the coming 12 months…”
https://finance.yahoo.com/news/2-strong-buy-penny-stocks-153448116.html